Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Wednesday, July 30, 2025.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Long-Term Uptrend (+90) - NBIX is in a strong uptrend that is likely to continue. While NBIX is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid NBIX?
MarketClub looks at technical strength and momentum to determine if the timing is right for NBIX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for NBIX
The long-term trend has been UP since Jul 3rd, 2025 at 130.46
The intermediate-term trend has been UP since Apr 28th, 2025 at 107.54
The short-term trend has been UP since Jul 29th, 2025 at 135.00
Smart Scan Analysis for NBIX
Based on our trend formula, NBIX is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 134.270 | 135.380 | 133.085 | 134.220 | +0.510 |
| Prev. Close | Volume | Bid | Ask | Time |
| 134.190 | 889266 | 2025-07-29 15:59:51 |
| Year High | 126.98 | Year High Date | 2018-09-13 |
| Year Low | 74.12 | Year Low Date | 2018-01-17 |
| 52wk High | 157.9799 | 52wk High Date | 2024-08-01 |
| 52wk Low | 84.23 | 52wk Low Date | 2025-04-09 |
| Year End Close | 7.48 | Average Volume | 815,604 |
| Shares Outstanding | 98,966 | Short Interest | 2,757,358 |
| % Institutional | 82.1 | Market Cap | 8,737M |
| Assets | 368,770,000M | Liabilities | 115,200,000M |
| P/E Ratio | 45.3254 | Beta | 0.3 |
| Volatility | 65.12 |